Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Thyroid Gland Papillary Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04500925
What this trial is testing

The Incidence of Postoperative Re-stratification for Recurrence in Well-differentiated Thyroid Cancer - A Single Tertiary Israeli Center Experience

Who this might be right for
Well Differentiated Thyroid CarcinomaPapillary Thyroid Cancer
Tel-Aviv Sourasky Medical Center 301
Early research (Phase 1)Study completedNCT00062348
What this trial is testing

Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver Metastases

Who this might be right for
Colorectal CancerHead and Neck CancerMetastatic Cancer
European Organisation for Research and Treatment of Cancer - EORTC 27
Not applicableStudy completedNCT00068497
What this trial is testing

Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer

Who this might be right for
Anaplastic Thyroid CancerInsular Thyroid CancerMetastatic Parathyroid Cancer+83 more
National Cancer Institute (NCI) 40
Not applicableActive Not RecruitingNCT07062211
What this trial is testing

Diagnostic Accuracy of Fluorodeoxyglucose-18 PET in the Evaluation of RPTC With Patient's Raised Thyroglobulin Level

Who this might be right for
Papillary Thyroid Carcinoma
Superior University 39
Testing effectiveness (Phase 2)Study completedNCT00134043
What this trial is testing

Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurrent Thyroid Cancer

Who this might be right for
Insular Thyroid CancerRecurrent Thyroid CancerStage II Follicular Thyroid Cancer+4 more
National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)Study completedNCT01502410
What this trial is testing

Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer

Who this might be right for
Childhood Hepatocellular CarcinomaPapillary Thyroid CancerPreviously Treated Childhood Rhabdomyosarcoma+4 more
National Cancer Institute (NCI) 20
Not applicableUnknownNCT06468696
What this trial is testing

Improvements in Thyroid Tumor Surgery and the Prognosis, Diagnosis, Recurrence and Metastasis of Patients

Who this might be right for
Papillary Thyroid CancerLymph Node MetastasisCarcinogenesis
Second Affiliated Hospital of Xi'an Jiaotong University 170
Testing effectiveness (Phase 2)Study completedNCT00061906
What this trial is testing

Celecoxib in Treating Patients With Progressive Metastatic Differentiated Thyroid Cancer

Who this might be right for
Head and Neck Cancer
Ohio State University Comprehensive Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT00019331
What this trial is testing

Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors

Who this might be right for
Colorectal CancerEndometrial CancerHead and Neck Cancer+6 more
National Cancer Institute (NCI)
Not applicableEnded earlyNCT05003856
What this trial is testing

Radiofrequency Ablation for the Treatment of Benign or Low Risk Thyroid Nodule

Who this might be right for
Benign Thyroid Gland NeoplasmRecurrent Thyroid Gland CarcinomaThyroid Gland Follicular Tumor of Uncertain Malignant Potential+2 more
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Ended earlyNCT04985604
What this trial is testing

Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors

Who this might be right for
MelanomaSolid TumorCRAF Gene Amplification+20 more
Day One Biopharmaceuticals, Inc. 23
Not applicableEnded earlyNCT00416949
What this trial is testing

Iodine I 131 in Treating Patients With Thyroid Cancer

Who this might be right for
Head and Neck Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 9
Testing effectiveness (Phase 2)Study completedNCT00519896
What this trial is testing

Sunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid Cancer

Who this might be right for
Recurrent Thyroid CancerStage IVA Follicular Thyroid CancerStage IVA Papillary Thyroid Cancer+5 more
University of Washington 35
Testing effectiveness (Phase 2)Study completedNCT00381641
What this trial is testing

Sunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery

Who this might be right for
Differentiated Thyroid Gland CarcinomaRecurrent Thyroid Gland CarcinomaRefractory Thyroid Gland Carcinoma+16 more
National Cancer Institute (NCI) 63
Testing effectiveness (Phase 2)Study completedNCT00118248
What this trial is testing

Tanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid Cancer

Who this might be right for
Recurrent Thyroid CancerStage IV Follicular Thyroid CancerStage IV Papillary Thyroid Cancer+1 more
National Cancer Institute (NCI) 41
Early research (Phase 1)Study completedNCT00004074
What this trial is testing

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

Who this might be right for
Advanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more
National Cancer Institute (NCI) 15
Early research (Phase 1)Study completedNCT00004062
What this trial is testing

Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid Cancer

Who this might be right for
Head and Neck Cancer
Lucille P. Markey Cancer Center at University of Kentucky
Testing effectiveness (Phase 2)Study completedNCT00085293
What this trial is testing

Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131

Who this might be right for
Recurrent Thyroid CancerStage IVA Follicular Thyroid CancerStage IVA Papillary Thyroid Cancer+4 more
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Looking for participantsNCT06087068
What this trial is testing

Thyroxine Replacement Therapy After Lobectomy for Low-risk Papillary Thyroid Carcinoma

Who this might be right for
Thyroid CancerSurgeryRecurrence
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 140
Testing effectiveness (Phase 2)Study completedNCT00729157
What this trial is testing

Aflibercept in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy

Who this might be right for
Recurrent Thyroid Gland CarcinomaStage III Thyroid Gland Follicular CarcinomaStage III Thyroid Gland Papillary Carcinoma+2 more
National Cancer Institute (NCI) 41
Next Page